Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Pharming Group N.V.
< Previous
1
2
Next >
Pharming Group to participate in March investor conference
February 28, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
February 27, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in February investor conference
February 10, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
January 21, 2025
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces public cash offer to the shareholders of Abliva AB
December 15, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces positive topline data in pediatric clinical trial of leniolisib
December 11, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in November investor conference
November 05, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports third quarter 2024 financial results and provides business update
October 24, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report third quarter 2024 financial results on October 24
October 10, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
October 10, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
September 26, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in September investor conferences
September 04, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports second quarter and first half 2024 financial results and provides business update
August 01, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report second quarter and first half 2024 financial results on August 1
July 18, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in June investor conferences
June 03, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
May 21, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in May investor conference
May 20, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports first quarter 2024 financial results and provides business update
May 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
April 24, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
April 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in April investor conferences
April 03, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports fourth quarter and full year 2023 financial results
March 14, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
February 29, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in February investor conferences
February 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
January 08, 2024
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
December 13, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
November 21, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to participate in November investor conferences
November 01, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group reports third quarter 2023 financial results
October 26, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
Pharming Group to report third quarter 2023 financial results on October 26
October 12, 2023
From
Pharming Group N.V.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today